(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DRIPHORM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DRIPHORM

ST13

US500000075938646

Class

29

Filing

75938646

Registration

2650026

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

09/20/2022

Trademark type

Word

Nice classes

29

Filing date

03/08/2000

Registration date

11/12/2002

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/20/2022

Last transaction

09/20/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/15/2001

First use in commerce

01/15/2001

Drawing code

1

Owner type

03

Owner location

Altona North, Victoria, AU

Examiner

FOSDICK, GEOFFREY

Law office

M20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Clover Corporation Limited
Clover Corporation Limited

Representatives

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP

Technical classification

Nice Classes

Class 29

Vienna Codes

No Vienna codes available.

Goods and services

Class 29

Edible oilsmicro-encapsulated oils and emulsified oils

Publications

History of USPTO decisions and trademark events.

31 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/20/2022

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

09/20/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/20/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/20/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

03/25/2022

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED

12/21/2012

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/21/2012

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/21/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/21/2012

E89R

TEAS SECTION 8 & 9 RECEIVED

11/29/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/31/2009

PLGL

ASSIGNED TO PARALEGAL

03/31/2009

E815

TEAS SECTION 8 & 15 RECEIVED

03/26/2009

CFIT

CASE FILE IN TICRS

02/21/2008

CORV

REVIEW OF CORRESPONDENCE COMPLETE

09/01/2006

MAIL

PAPER RECEIVED

08/21/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

11/12/2002

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/03/2002

DOCK

ASSIGNED TO EXAMINER

08/29/2002

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/27/2002

MAIL

PAPER RECEIVED

08/08/2002

IUAF

USE AMENDMENT FILED

08/05/2002

EX2G

SOU EXTENSION 2 GRANTED

02/28/2002

EXT2

SOU EXTENSION 2 FILED

02/04/2002

EX1G

SOU EXTENSION 1 GRANTED

08/08/2001

EXT1

SOU EXTENSION 1 FILED

07/17/2001

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

02/06/2001

PUBO

PUBLISHED FOR OPPOSITION

11/14/2000

NPUB

NOTICE OF PUBLICATION

10/13/2000

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/07/2000

DOCK

ASSIGNED TO EXAMINER

08/07/2000

Continuous trademark protection

Get notified about every new filing that threatens DRIPHORM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.